会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 5-aminoflavone derivatives
    • 5-氨基黄酮衍生物
    • US5539112A
    • 1996-07-23
    • US464093
    • 1995-06-05
    • Tsutomu AkamaShun-ichi IkedaYasushi ShidaMasaji KasaiHiroyuki IshidaUichiro KimuraKatsushige GomiHiromitsu SaitoKimihisa Ueno
    • Tsutomu AkamaShun-ichi IkedaYasushi ShidaMasaji KasaiHiroyuki IshidaUichiro KimuraKatsushige GomiHiromitsu SaitoKimihisa Ueno
    • C07D311/30C07D413/12
    • C07D311/30
    • 5-Aminoflavone derivatives represented by the formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are the same or different and represent hydrogen, substituted or unsubstituted lower alkyl, lower alkenyl, halogen-substituted or unsubstituted lower alkanoyl or lower alkoxycarbonyl, X.sup.1, X.sup.2, Y.sup.1 and Y.sup.2 are the same or different and represent hydrogen, halogen or lower alkyl, at least one of X.sup.1 and X.sup.2 represents halogen or lower alkyl, X.sup.3 represents hydrogen, substituted or unsubstituted lower alkyl, lower alkenyl, lower alkynyl, halogen, hydroxy, substituted or unsubstituted lower alkoxy, NR.sup.5 R.sup.6 (wherein R.sup.5 and R.sup.6 are the same or different and represent hydrogen, or substituted or unsubstituted lower alkyl, or R.sup.5 and R.sup.6 are taken together to form a heterocyclic group containing the nitrogen atom in the ring), lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, carboxy, lower alkoxycarbonyl, lower alkanoyl, adizo, cyano, substituted or unsubstituted carbamoyl or lower alkylthiothiocarbonyl: or pharmaceutically acceptable salts thereof.
    • 由式(I)表示的5-氨基黄酮衍生物:其中R 1,R 2,R 3和R 4相同或不同,表示氢,取代或未取代的低级烷基,低级烯基,卤素取代或未取代的低级 烷酰基或低级烷氧基羰基,X 1,X 2,Y 1和Y 2相同或不同,表示氢,卤素或低级烷基,X 1和X 2中的至少一个表示卤素或低级烷基,X 3表示氢,取代或未取代的低级烷基,低级 烯基,低级炔基,卤素,羟基,取代或未取代的低级烷氧基,NR5R6(其中R5和R6相同或不同,代表氢,或取代或未取代的低级烷基,或R5和R6一起形成含有 环中的氮原子),低级烷硫基,低级烷基亚磺酰基,低级烷基磺酰基,羧基,低级烷氧基羰基,低级烷酰基,二唑基,氰基,取代或未取代的氨基甲酰基或低级烷硫基硫代 辛基或其药学上可接受的盐。
    • 9. 发明授权
    • DC-89 derivatives
    • DC-89衍生物
    • US5332740A
    • 1994-07-26
    • US46365
    • 1993-04-13
    • Hiromitsu SaitoSatoru NagamuraAkira AsaiEiji KobayashiKatsushige Gomi
    • Hiromitsu SaitoSatoru NagamuraAkira AsaiEiji KobayashiKatsushige Gomi
    • C07D471/04A61K31/435A61K31/495C07D487/04
    • C07D471/04
    • Novel DC-89 derivatives represented by general formula (I): ##STR1## wherein X represents Cl or Br; R.sup.1 represents hydrogen, CONR.sup.2 R.sup.3 (in which R.sup.2 and R.sup.3 independently represent hydrogen, a straight-chain or branched alkyl group having 1 to 4 carbon atoms or phenyl group), ##STR2## (in which n represents an integer of 4 to 7), ##STR3## (in which R.sup.4 represents oxygen, N--CH.sub.3 or N--CH.sub.2 CH.sub.2 NH.sub.2), ##STR4## (in which R.sup.5 R.sup.6 and R.sup.7 independently represent a straight-chain or branched alkyl group having 1 to 4 carbon atoms); and ##STR5## (in which Y represents hydrogen or CO.sub.2 CH.sub.3); provided that when R.sup.1 is hydrogen, CONR.sup.2 R.sup.3 or SiR.sup.5 R.sup.6 R.sup.7, ##STR6## and pharmaceutically acceptable salts thereof have an excellent anti-tumor activity and are expected to be useful as anti-tumor compositions.
    • 由通式(I)表示的新型DC-89衍生物:其中X表示Cl或Br; R1表示氢,CONR2R3(其中R2和R3独立地表示氢,具有1至4个碳原子的直链或支链烷基或苯基),其中n表示4至7的整数, (其中R 4表示氧,N-CH 3或N-CH 2 CH 2 NH 2),其中R 5和R 7独立地表示碳原子数1〜4的直链或支链烷基。 和其中Y表示氢或CO 2 CH 3)。 条件是当R 1是氢时,CONR 2 R 3或SiR 5 R 6 R 7,其药学上可接受的盐具有优异的抗肿瘤活性,并且预期可用作抗肿瘤组合物。